Baird Financial Group
SMTI icon

Baird Financial Group’s Sanara MedTech SMTI Stock Holding History

Baird Financial Group’s Portfolio SMTI Stock Details SMTI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$497K Hold
21,075
– – ﹤0.01% 1545
2026
Q1 		$362K Sell
21,075
-739,218
-97% -$15.2M ﹤0.01% 1580
2025
Q4 		$17.8M Buy
+760,293
New +$19.6M 0.03% 402

Other funds holding SMTI

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return
SWM
Stonebridge Wealth Management Oak Brook, Illinois $112M AUM 23.07% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Squarepoint
Squarepoint New York $90.5B AUM 33.95% 1-Year Est. Return

Baird Financial Group's SMTI Position: Q2 2026 in Review

Baird Financial Group held its Sanara MedTech (SMTI) position steady in Q2 2026 at 21,075 shares worth $497K. The position accounts for ﹤0.01% of the portfolio, ranked #1545.

Baird Financial Group first reported a position in SMTI in Q4 2025 and has held it in 3 quarters since. The position peaked at $17.8M in Q4 2025. 75 funds tracked by Wall St. Rank hold SMTI as of Q2 2026.

  • Baird Financial Group held 21,075 shares of Sanara MedTech worth $497K as of Q2 2026.
  • Baird Financial Group left its Sanara MedTech share count unchanged in Q2 2026.
  • Sanara MedTech made up ﹤0.01% of Baird Financial Group's portfolio in Q2 2026, its #1545 holding.
  • Baird Financial Group first reported a position in Sanara MedTech in Q4 2025 and has held it in 3 quarters since.
  • Baird Financial Group's Sanara MedTech position peaked at $17.8M in Q4 2025.
  • 75 funds tracked by Wall St. Rank held Sanara MedTech as of Q2 2026.

Based on Baird Financial Group's 13F filing for Q2 2026, filed 12 Aug 2026.